Artha Sootra - Company Dashboard

Governance Classic Home

Blue Jet Healthcare LtdPharmaceuticalsINE0KBH01020Standalone₹531.75+35.25 (+7.10%)

Valuation

Market Cap₹9.23K Cr

TTM PE39.25x

Forward PE37.85x

PEG-7.49

Book Value₹78.40

P/B6.78x

TTM EPS₹13.55

Fwd EPS₹14.05

TTM Revenue₹885.67 Cr

TTM PAT₹234.91 Cr

TTM EBITDA₹271.18 Cr

TTM EBIT₹246.16 Cr

Last Qtr PAT₹78.26 Cr

Last Qtr EBITDA₹98.08 Cr

Last Qtr EBIT₹91.37 Cr

Profitability

ROE17.27%

ROCE24.00%

TTM NPM26.52%

TTM EBITDA %30.62%

Curr OPM25.38%

Last OPM24.98%

Curr NPM—

Last NPM—

Curr EPS₹4.51

Last EPS₹3.71

Balance sheet

Equity₹34.69 Cr

Reserve₹1.33K Cr

Total Debt₹1.08 Cr

D/E0.00x

Interest %0.84%

Curr Interest₹0.66 Cr

Price / range

Close₹531.85

vs 52W High-22.70%

vs 52W Low+63.55%

MA50—

MA200—

Returns

1D+7.14%

1W+2.66%

1M-1.90%

3M-8.63%

6M+11.63%

1Y-12.42%

2Y+12.69%

3Y—

5Y—

Diwali+0.52%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	130.40	3.70%
DIVISLAB	10037.50	₹2.66L Cr	90.60	17.55%
TORNTPHARM	4738.50	₹1.60L Cr	83.32	11.07%
LAURUSLABS	2323.80	₹1.25L Cr	120.09	17.24%
ZYDUSLIFE	1188.10	₹1.20L Cr	38.84	11.33%
DRREDDY	1374.00	₹1.15L Cr	413.86	2.50%
CIPLA	1402.00	₹1.13L Cr	42.73	7.49%
MANKIND	2537.90	₹1.05L Cr	45.48	13.10%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	293.11-17.4%	234.67	192.41	165.48	354.76	947.32
Other Income	15.24	22.92	13.21	24.27	8.25	68.65
Total Income	308.35-15.1%	257.59	205.62	189.75	363.01	1,015.98
Interest	0.66	0.58	0.34	4.63	0.69	6.24
Expenditure	-202.40+15.7%	-170.44	-151.85	-121.03	-240.15	-683.46
PBDT	0	0	0	0	0	0
EBITDA	98.08-18.9%	71.27	46.88	54.95	121	294.10
Depreciation	-6.71	-6.46	-5.98	-5.87	-5.70	-24
EBIT	91.37-20.8%	64.81	40.90	49.08	115.30	270.10
PBT	105.95-13.8%	87.15	53.78	68.73	122.86	332.51
Tax	-27.68	-22.81	-13.61	-16.59	-31.69	-84.70
Equity	34.69	34.69	34.69	0	34.69	34.69
OPM	34.36	33.83	26.16	41.53	33.84	32.73
Net Profit	78.26-14.2%	64.34	40.17	52.14	91.17	247.82
NPM	25.38	24.98	19.54	31.51	25.12	24.39
EPS	4.51-14.3%	3.71	2.32	3.01	5.26	14.29

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24
Revenue	947.32-8.0%	1,029.99+44.7%	711.60
Other Income	68.65	46.26	28.86
Total Income	1,015.98-5.6%	1,076.24+45.3%	740.46
Expenditure	-683.46-2.0%	-670.14-31.2%	-510.62
Interest	-6.24	-0.10	-0.16
PBDT	0	0	0
EBITDA	294.10-22.1%	377.74+64.8%	229.23
Depreciation	-24	-17.79	-28.09
EBIT	270.10-25.0%	359.95+79.0%	201.14
PBT	332.51-18.1%	406.10+84.5%	220.10
Tax	-84.70	-100.90	-56.34
Equity	34.69	34.69	0
OPM (%)	32.73	37.73	30.00
Net Profit	247.82-18.8%	305.20+86.4%	163.75
NPM (%)	24.39	28.36	22.00
EPS (Rs)	14.29-18.8%	17.59+86.3%	9.44
CEPS	14.29	17.59	9.44

Metric	FY25-26
Revenue	947.32
Other Income	68.65
Total Income	1,015.98
Interest	6.24
Expenditure	-683.46
PBDT	0
EBITDA	294.10
Depreciation	-24
EBIT	270.10
PBT	332.51
Tax	-84.70
Equity	34.69
OPM	32.73
Net Profit	247.82
NPM	24.39
EPS	14.29

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	947.32-8.0%	1,029.99
Other Income	68.65	46.26
Total Income	1,015.98-5.6%	1,076.24
Expenditure	-683.46-2.0%	-670.14
Interest	-6.24	-0.10
PBDT	0	0
EBITDA	294.10-22.1%	377.74
Depreciation	-24	-17.79
EBIT	270.10-25.0%	359.95
PBT	332.51-18.1%	406.10
Tax	-84.70	-100.90
Equity	34.69	34.69
OPM (%)	32.73	37.73
Net Profit	247.82-18.8%	305.20
NPM (%)	24.39	28.36
EPS (Rs)	14.29-18.8%	17.59
CEPS	14.29	17.59

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	1.2	11 Sep 2026
2025	Final Dividend	1.2	19 Sep 2025
2024	Final Dividend	1	18 Sep 2024
2024	Final Dividend	1	17 Sep 2024

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split